🇺🇸 FDA
Patent

US 8916172

MVA expressing modified HIV envelope, gag, and pol genes

granted A61KA61K2039/525A61K2039/53

Quick answer

US patent 8916172 (MVA expressing modified HIV envelope, gag, and pol genes) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/525, A61K2039/53, A61K2039/545, A61K2039/57